Showing 621 - 640 results of 790 for search '"cirrhosis"', query time: 0.07s Refine Results
  1. 621

    Neisseria Gonorrhoeae Spontaneous Bacterial Peritonitis by George Mwandia, Ryan Q. Simon, Hari Polenakovik, Katelyn J. Booher

    Published 2021-01-01
    “…We describe a case of gonococcal spontaneous bacterial peritonitis (SBP) in a 48-year-old sexually active female with alcoholic cirrhosis and chronic hepatitis B. She was admitted with fever, abdominal pain and distension without dysuria, dyspareunia, or vaginal discharge. …”
    Get full text
    Article
  2. 622

    Dietary Interventions and Physical Activity as Crucial Factors in the Prevention and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease by Paweł Rajewski, Jakub Cieściński, Piotr Rajewski, Szymon Suwała, Alicja Rajewska, Maciej Potasz

    Published 2025-01-01
    “…MASLD is one of the leading causes of hepatocellular carcinoma, cirrhosis, and liver transplantation, as well as a significant risk factor for cardiovascular disease and mortality. …”
    Get full text
    Article
  3. 623

    Coexistence of adenomyomatosis in a left-sided gallbladder: a case report by Mohamed Tolba, Hadeer Hafez, John Adel

    Published 2025-01-01
    “…Case presentation We report an old man with a history of hepatitis C, carcinoma and liver cirrhosis complained of sudden epigastric pain. A CT scan revealed the presence of an LSG, which’s a congenital anomaly. …”
    Get full text
    Article
  4. 624
  5. 625

    Diagnosis and management of de novo inflammatory bowel disease after solid organ transplantation in the era of biologic therapy: a case series by Willie Mohammed Johnson, Byron P. Vaughn, Nicholas Lim

    Published 2025-01-01
    “…Indication for transplant were alcohol-related cirrhosis (n = 2), idiopathic fulminant hepatic failure (n = 1), metabolic dysfunction-associated steatotic liver disease (n = 1), and IgA nephropathy (n = 1). …”
    Get full text
    Article
  6. 626

    Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Inter... by Andrew Trigg, Eric Chan, Helen Kitchen, Tom Willgoss, Kai Fai Ho, Renee Pierson, Jane Scott

    Published 2019-02-01
    “…Greater symptom severity and worse impact scores were associated with liver cirrhosis, depression, severe fatigue and health limitations. …”
    Get full text
    Article
  7. 627

    The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease by Muhammad Abdel-Gawad, Hamdiy Mahfouz, Mona Abdelmeguid, Gehad M.A.-A. Hassan, Marwa Khalaf, Hani S. Aboalam

    Published 2023-10-01
    “…Background and aim Nonalcoholic fatty liver disease (NAFLD) involves a spectrum of liver disorders, ranging from benign steatosis to nonalcoholic steato-hepatitis to fibrosis and cirrhosis. This study aims to evaluate the diagnostic validity of using s.autotaxin (ATX) as a noninvasive bio-marker of fibrosis in NAFLD cases as compared with Controlled Attenuation Parameter and scoring systems of hepatic steatosis. …”
    Get full text
    Article
  8. 628

    The Role of Monocyte/Macrophage and CXCR3 in Differentiation between Recurrent Hepatitis C and Acute Cellular Rejection Postliver Transplantation by Asmaa Ibrahim Gomaa, Nermine Ahmed Ehsan, Ahmed A. Elrefaei, Mervat Mohamed Sultan, Maha Mohamed Elsabaawy

    Published 2018-01-01
    “…Liver transplantation (LT) is the recommended treatment for patients with advanced liver disease and cirrhosis in all guidelines, mostly as a complication of HCV. …”
    Get full text
    Article
  9. 629

    Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease by Alfredo Smiriglia, Nicla Lorito, Marina Bacci, Angela Subbiani, Francesca Bonechi, Giuseppina Comito, Marta Anna Kowalik, Andrea Perra, Andrea Morandi

    Published 2025-01-01
    “…Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a spectrum of hepatic disorders, ranging from simple steatosis to steatohepatitis, with the most severe outcomes including cirrhosis, liver failure, and hepatocellular carcinoma. …”
    Get full text
    Article
  10. 630

    Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-analysis by Abdullah A. Awadh, Abdulrahman A. Alharthi, Basil A. Alghamdi, Seraj T. Alghamdi, Mohammed K. Baqays, Ibrahim S. Binrabaa, Israa A. Malli

    Published 2024-12-01
    “…Introduction: Hepatitis B and C are viral infections causing chronic liver inflammation and, when left untreated, lead to cirrhosis and a risk for hepatocellular carcinoma, the most common type of primary liver cancer with high mortality. …”
    Get full text
    Article
  11. 631

    The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma by Karim Y. A. Shaheen, Abeer I. Abdel-Mageed, Eslam Safwat, Ashraf M. AlBreedy

    Published 2015-01-01
    “…Patients and Methods. 40 HCCs, 30 liver cirrhosis patients, and 30 healthy subjects were enrolled. …”
    Get full text
    Article
  12. 632

    Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake by Kenichiro Yasutake, Motoyuki Kohjima, Manabu Nakashima, Kazuhiro Kotoh, Makoto Nakamuta, Munechika Enjoji

    Published 2012-01-01
    “…Some patients with liver cirrhosis (LC) have decreased dietary energy and protein intake, while the number of LC patients with overeating and obesity is increasing, indicating that the nutritional state of LC patients has a broad spectrum. …”
    Get full text
    Article
  13. 633

    Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China by Tianyi Ren, Huan Wang, Ruihong Wu, Junqi Niu

    Published 2017-01-01
    “…The AUROCs of GPR and Fib-4 for fibrosis (0.77 versus 0.75, P=0.14), significant fibrosis (0.70 versus 0.70, P=0.22), extensive fibrosis (0.71 versus 0.68, P=0.13), and cirrhosis (0.64 versus 0.67, P=0.24) were comparable. …”
    Get full text
    Article
  14. 634

    Spleen and Liver Stiffness Evaluation by ARFI Imaging: A Reliable Tool for a Short-Term Monitoring of Portal Hypertension? by Andreas Binzberger, Mark Hänle, Matthias Pfahler, Wolfgang Kratzer, Thomas Seufferlein, Eugen Zizer

    Published 2022-01-01
    “…We prospectively assessed portal hypertension by HVPG and corresponding elastography of the liver and spleen in 31 patients with liver cirrhosis and an indication for primary prophylaxis by non-cardio selective beta-blockers. …”
    Get full text
    Article
  15. 635

    OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease by Elena Paschetta, Paola Belci, Anna Alisi, Daniela Liccardo, Renato Cutrera, Giovanni Musso, Valerio Nobili

    Published 2015-01-01
    “…Several studies suggest that the chronic intermittent hypoxia (CIH) of OSAS patients may per se trigger liver injury, inflammation, and fibrogenesis, promoting NAFLD development and the progression from steatosis to steatohepatitis, cirrhosis, and hepatocellular carcinoma. In NAFLD patients, liver disease may be caused by hypoxia both indirectly by promoting inflammation and insulin resistance and directly by enhancing proinflammatory cytokine production and metabolic dysregulation in liver cells. …”
    Get full text
    Article
  16. 636

    Antiphospholipid Syndrome as a Cause of Recurrent Portal Vein Thrombosis in a Man with a Medical History of other Thrombosis by R. G. Sayfutdinov, R. R. Saifutdinov, R. R. Akhunova, T. V. Saifutdinova, G. R. Absalyamova, T. V. Dvoryankina, G. R. Akhunova

    Published 2023-05-01
    “…For several years, the patient had the diagnosis of cirrhosis based on the presence of signs of portal hypertension. …”
    Get full text
    Article
  17. 637

    Association between Serum Albumin Concentration and Ketosis Risk in Hospitalized Individuals with Type 2 Diabetes Mellitus by Po-Chung Cheng, Shang-Ren Hsu, Yun-Chung Cheng

    Published 2016-01-01
    “…Individuals without measurement of serum albumin, urine ketone, or hemoglobin A1C, or harboring active infection, myocardial infarction, cerebrovascular event, cirrhosis, malignancy, or overt proteinuria were excluded. …”
    Get full text
    Article
  18. 638

    Ligation of Left Renal Vein for Spontaneous Splenorenal Shunt to Prevent Portal Hypoperfusion after Orthotopic Liver Transplantation by Lampros Kousoulas, Kristina Imeen Ringe, Michael Winkler, Frank Lehner, Nicolas Richter, Juergen Klempnauer, Fabian Helfritz

    Published 2013-01-01
    “…We report a case of recovered portal flow by ligation of the left renal vein on the first postoperative day after orthotopic liver transplantation of a 54-year-old female with alcoholic liver cirrhosis, chronic kidney failure, and spontaneous splenorenal shunt. …”
    Get full text
    Article
  19. 639

    Disulfiram Induced Psychosis: A Case Report by D. R. Survilaitė, R. Žemaitytė

    Published 2024-02-01
    “…The drug should be used with caution in people with a history of heart disease, diabetes mellitus, hypothyroidism, cerebral damage, nephritis, liver cirrhosis, epilepsy. Caution is recommended for patients who use benzodiazepines, some antibiotics, anticoagulants, tricyclic antidepressants. …”
    Get full text
    Article
  20. 640

    Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency by M. V. Mayevskaya, V. T. Ivashkin, M. S. Zharkova, T. P. Nekrasova, G. I. Ayusheva, R. V. Maslennikov

    Published 2016-08-01
    “…Early detection of DLAL patients and adequate treatment can prevent development of the liver cirrhosis associated to this disease, as well as cardio-vascular complications.…”
    Get full text
    Article